Top

Published in:

Open Access 01-12-2012 | Case report

Surgical approach to multifocal hepatocellular carcinoma with portal vein thrombosis and arterioportal shunt leading to portal hypertension and bleeding: a case report

Authors: Francesca Ratti, Federica Cipriani, Michele Paganelli, Gianfranco Ferla, Luca AM Aldrighetti

Published in: World Journal of Surgical Oncology | Issue 1/2012

Abstract

It is reported the case of a 69 years man who presented to the Emergency Room because of pain and abdominal distension from ascites. After admission and paracentesis placement, he developed a digestive hemorrhage due to oesophageal varices from portal ipertension secondary to the formation of a portal shunt concomitant with a multifocal HepatoCellular Carcinoma (HCC) with portal vein thrombosis (PVT). The patient underwent endoscopic varices ligation, twice transarterial embolization (TAE) of arterial branches feeding the shunt and subsequent left hepatectomy. During the postoperative course he developed mild and transient signs of liver failure and was discharged in postoperative day 16. He is alive and disease free 8 months after surgery.

Available only for authorised users

Lazaridis KN, Kamath PS: Images in hepatology. Arterioportal fistula causing recurrent variceal bleeding. J Hepatol. 1998, 29: 142-10.1016/S0168-8278(98)80189-X.CrossRefPubMed

Velázquez RF, Rodríguez M, Navascués CA, Linares A, Pérez R, Sotorríos NG, Martínez I, Rodrigo L: Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003, 37: 520-527. 10.1053/jhep.2003.50093.CrossRefPubMed

Morse SS, Sniderman KW, Galloway S, Rapoport S, Ross GR, Glickman MG: Hepatoma, arterioportal shunting, and hyperkinetic portal hypertension: therapeutic embolization. Radiology. 1985, 155: 77-82.CrossRefPubMed

Rahbari NN, Mehrabi A, Mollberg NM, Muller SA, Koch M, Buchler MW, Weitz J: Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg. 2011, 253 (3): 453-69. 10.1097/SLA.0b013e31820d944f.CrossRefPubMed

Clavien PA, Barkun J, de Oliveira M, Vauthey JN, Dindo D, Schulik RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vontlanthen R, Padbudy R, Cameron JL, Makuuchi M: The Clavien-Dindo classification of surgical complications. Five-years experience. Ann Surg. 2009, 250: 187-196. 10.1097/SLA.0b013e3181b13ca2.CrossRefPubMed

Ngan H, Peh WC: Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance. Clin Radiol. 1997, 52: 36-40. 10.1016/S0009-9260(97)80303-0.CrossRefPubMed

Okuda K, Musha H, Yamasaki T, Jinnouchi S, Nagasaki Y, Kubo Y, Shimokawa Y, Nakayama T, Kojiro M, Sakamoto K, Nakashima T: Angiographic demonstration of intrahepatic arterio-portal anastomoses in hepatocellular carcinoma. Radiology. 1977, 122: 53-58.CrossRefPubMed

Luo MY, Shan H, Jiang ZB, Liang WW, Zhang JS, Li LF: Capability of multidetector CT to diagnose hepatocellular carcinoma-associated arterioportal shunt. World J Gastroenterol. 2005, 11: 2666-2669.PubMedCentralCrossRefPubMed

Choi BI, Lee KH, Han JK, Lee JM: Hepatic arterioportal shunts: dynamic CT and MR features. Korean J Radiol. 2002, 3 (1): 1-15. 10.3348/kjr.2002.3.1.1.PubMedCentralCrossRefPubMed

10.

Bruix J, Sherman M, Llovet JM, Beaugard M, Lencioni R, Burroughs AK, Christenses E, Pagliaro L, Colombo M, Rodes J, for the EASL panel of experts on HCC: Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona-2000 EASL conference. Journal of Hepatology. 2001, 35: 421-430. 10.1016/S0168-8278(01)00130-1.CrossRefPubMed

11.

Llovet JM, Bruix J: Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol. 2008, 48 (Supp): 20-37.CrossRef

12.

Bruix J, Llovet JM: Major achievements in hepatocellular carcinoma. Lancet. 2009, 373: 614-616. 10.1016/S0140-6736(09)60381-0.CrossRefPubMed

13.

Ishii H, Sonoyama T, Nakashima S, Nagata H, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Ochiai T, Kokuba Y, Sakakura C, Otsuji E: Surgical treatment of hepatocellular carcinoma with severe intratumoral arterioportal shunt. World J Gastroenterol. 2010, 16 (25): 3211-3214. 10.3748/wjg.v16.i25.3211.PubMedCentralCrossRefPubMed

14.

Mamada Y, Yoshida H, Taniai N, Bandou K, Mizuguchi Y, Kakinuma D, Ishikawa Y, Akimaru K, Tajiri T, Naito Z: Major arterioportal shunt caused by hepatocellular carcinoma. J Nihon Med Sch. 2007, 74 (4): 314-318. 10.1272/jnms.74.314.CrossRef

15.

Carey W: Portal hypertension: diagnosis and management with particular reference to variceal hemorrhagex. J Dig Dis. 2011, 12 (1): 25-32. 10.1111/j.1751-2980.2010.00473.x.CrossRefPubMed

16.

Huang MS, Lin Q, Jiang ZB, Zhu KS, Guan SH, Li ZR, Shan H: Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World J Gastroenterol. 2004, 10: 825-829.PubMed

17.

Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M: Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005, 12: 16-22. 10.1007/s00534-004-0965-9.CrossRefPubMed

18.

Buix J, Llovet JM: Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002, 35 (3): 519-24. 10.1053/jhep.2002.32089.CrossRef

19.

Capussotti L, Ferrero A, Viganò L, Polastri R, Tabone M: Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines. Eur J Surg Oncol. 2009, 35 (1): 11-5. 10.1016/j.ejso.2007.06.005.CrossRefPubMed

20.

Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Brù C, Rodes J, Bruix J: Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999, 29 (1): 62-7. 10.1002/hep.510290145.CrossRefPubMed

21.

Yoshidome H, Takeuchi D, Kimura F, Shimizu H, Ohtsuka M, Kato A, Furukawa K, Yoshitomi H, Miyazaki M: Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: a single institution experience. J Am Coll Surg. 2011, 212 (5): 796-803. 10.1016/j.jamcollsurg.2011.01.002.CrossRefPubMed

22.

Minagawa M, Makuuchi M, Takayama T, Ohtomo K: Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg. 2001, 233 (3): 379-384. 10.1097/00000658-200103000-00012.PubMedCentralCrossRefPubMed

23.

Fong Y, Sun RL, Jarnagin W, Blumgart LH: An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999, 229 (6): 790-799. 10.1097/00000658-199906000-00005.PubMedCentralCrossRefPubMed

24.

Fuster J, Garcia-Valdecasas JC, Grande L, Tabet J, Bruix J, Anglada T, Taurà P, Lacy AM, Gonzalez X, Vilana R, Bru C, Sole M, Visa J: Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg. 1996, 223 (3): 297-302. 10.1097/00000658-199603000-00011.PubMedCentralCrossRefPubMed

25.

Capussotti L, Ferrero A, Viganò L, Muratore A, Polastri R, Bouzari H: Portal hypertension: contraindication to liver surgery?. World J Surg. 2006, 30 (6): 992-999. 10.1007/s00268-005-0524-9.CrossRefPubMed

26.

Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G, Grazi GL, Pinna AD: Is portal hypertension a contraindication to hepatic resection?. Ann Surg. 2009, 250 (6): 922-928. 10.1097/SLA.0b013e3181b977a5.CrossRefPubMed

27.

Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M: One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003, 138 (11): 1198-1206. 10.1001/archsurg.138.11.1198.CrossRefPubMed

Title: Surgical approach to multifocal hepatocellular carcinoma with portal vein thrombosis and arterioportal shunt leading to portal hypertension and bleeding: a case report
Authors: Francesca Ratti
Federica Cipriani
Michele Paganelli
Gianfranco Ferla
Luca AM Aldrighetti
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2012
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/1477-7819-10-34

At a glance: The STEP trials

Springer Medicine

Surgical approach to multifocal hepatocellular carcinoma with portal vein thrombosis and arterioportal shunt leading to portal hypertension and bleeding: a case report

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2012

Feasibility of purely laparoscopic resection of locally advanced rectal cancer in obese patients

A novel sialyl LeX expression score as a potential prognostic tool in colorectal cancer

Haematogenous abdominal wall metastasis of differentiated, alpha-fetoprotein-negative hepatocellular carcinoma after previous antiandrogen therapy within a site of lipoma manifestation since childhood

Optimal carbon dioxide insufflation pressure during robot-assisted thyroidectomy in patients with various benign and malignant thyroid diseases

Leiomyosarcoma of the inferior vena cava level II involvement: curative resection and reconstruction of renal veins

A survey of the educational environment for oncologists as perceived by surgical oncology professionals in India